https://www.indianpharmapost.com/biocon-q1fy23-consolidated-pat-falls-qoq-at-rs-1444-cr-127462022-07-28T00:00:00+05:30always0.9https://www.indianpharmapost.com/novartis-india-q1fy23-pat-jumps-to-rs-5238-cr-127472022-07-28T00:00:00+05:30always0.9https://www.indianpharmapost.com/dr-reddys-launches-bortezomib-for-injection-35-mg-single-dose-vial-in-the-us-market-127482022-07-28T00:00:00+05:30always0.9https://www.indianpharmapost.com/india-has-achieved-replacement-level-fertility-minister-pawar-127492022-07-28T00:00:00+05:30always0.9https://www.indianpharmapost.com/velocity-clinical-research-begins-european-expansion-with-german-site-acquisition-127502022-07-28T00:00:00+05:30always0.9https://www.indianpharmapost.com/strong-execution-in-q2-drives-full-year-2022-guidance-upgrade-for-sanofi-127512022-07-28T00:00:00+05:30always0.9https://www.indianpharmapost.com/pfizer-and-biontech-advance-covid-19-vaccine-strategy-with-study-start-of-next-generation-vaccine-candidate-127522022-07-28T00:00:00+05:30always0.9https://www.indianpharmapost.com/dr-lal-path-labs-q1-fy23-consolidated-pat-drops-to-rs-577-cr-127532022-07-28T00:00:00+05:30always0.9